Cite
MLA Citation
François Tison et al.. “A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's Disease.” Movement disorders, vol. 31, no. 9, 2016, pp. 1373–1380. http://access.bl.uk/ark:/81055/vdc_100037125176.0x00003a